Regarding prediction of toxicity, hypertension and HFSR were related to the AUC in the present series.
Second, preclinical and patient data already exists with regards to toxicity and tolerability of the drug in the setting of epilepsy, which could be built upon to improve clinical trials.
Data are limited with regard to toxicity of therapy in older patients in these settings.
There is no explicit statistical justification for doing so; neither are there any guidelines regarding the use of toxicity information from this additional cohort with respect to the modification of MTD if necessary.
With regard to toxicity, addition of axitinib to standard doses of pemetrexed and cisplatin did not lead to AEs that were unexpected, based on studies with single-agent axitinib [ 8] or pemetrexed/cisplatin alone [ 10] in advanced NSCLC.
This is the most comprehensive study investigating cryoprotectant agent toxicity in articular chondrocytes and has resulted in important information regarding the order of toxicity and interactions that occur between these agents.
Besides this massive diversity regarding the mechanisms of toxicity among NP, species and ecosystems, some more general questions attracted attention among researchers, namely the relevance of ions released (dissolved) from NP for NP-induced effects.
There is a significant variation between patients regarding the severity of toxicity following a given dose of radiotherapy.
In Tables 1 and 2 we summarize the available publications reporting data regarding the incidence of toxicity, including nephrotoxicity, neurotoxicity, and other adverse effects of polymyxins.
The study by Van Malenstein et al. was also restricted regarding the evaluation of toxicity and safety; tumor response was measured only once 6 weeks after the first treatment [ 11].
